Page 1
His ADHD symptoms can be disruptive, but there’s a great kid in there.
Now there’s a new way to help him out…
New for the treatment of ADHD

Spread (pages 2 and 3):
Introducing once-daily Intuniv
A new way to reach the kid within
Intuniv demonstrated significant improvement in ADHD symptoms, which can be disruptive.
New for the treatment of ADHD

To see all of the ads from this campaign, click here

Brand name: intuniv
Generic name/category: Guanfacine, Antihypertensive agents, Guanidines, Alpha-adrenergic agonists
Company: Shire
Country/Market: USA, North America
Indication(s)/use: attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: A new way to reach the kid within
Medium: Print ad
Size/duration: Three-page spread
Publication/Aired: Contemporary Pediatrics – November 2009

To see all of this brand’s ads on AdPharm, click here

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see the original post on AdPharm

Visit AdPharm.net for more pharmaceutical ads

Click on image to view ad details and full-size version on AdPharm

To see all of this brand’s ads on AdPharm, click here

Print ad

Print ad

Web banner

With the help of Rinaldi Communication Marketing, Mylan launched a vast ad campaign to advertise their recent implementation in the Canadian generics market.

Agency: Rinaldi Communication Marketing

Generic name/category: Corporate Communications
Company: Mylan
Country/Market: Canada, North America
Indication(s)/use: Awareness
Target: Healthcare Professionals (HCP) / Trade
Tagline: Pour vous et vos patients – For you and your patients
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: 2009

To see all of this brand’s ads on AdPharm, click here

6:32 a.m. Another moment to breathe

Another day to enjoy life with Zemaira.

Fast – The shortest infusion time
Pure – The only alpha-1 augmentation therapy approved by the FDA as highly purified
Convenient – Room-temperature storage
Supported – Extensive patient services

Brand name: Zemaira
Generic name/category: Alpha 1-proteinase inhibitor (Human), Human proteins, Acute phase proteins, Serine protease inhibitors
Company: CSL Behring
Country/Market: USA, North America
Indication(s)/use: chronic augmentation and maintenance therapy for adults with Alpha 1-proteinase inhibitor deficiency and emphysema
Target: Healthcare Professionals (HCP)
Tagline: Pure. And simple.
Medium: Print ad
Size/duration: single-page
Publication/Aired: Chest – September 2009

If you can draw a map to every bathroom in town…

Today is the day to talk to your doctor about overactive bladder and Toviaz – a pill that comes with a plan

A pill for overactive bladder that comes with a plan

To see all of this brand’s ads on AdPharm, click here